Comment on: Intravenous iron for critically ill children. Comparison of three dose regimens.

Pediatr Blood Cancer

Blood and Tissue Bank of Navarra, Servicio Navarro de Salud-Osasunbidea, Pamplona, Spain.

Published: April 2024

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.30857DOI Listing

Publication Analysis

Top Keywords

comment intravenous
4
intravenous iron
4
iron critically
4
critically ill
4
ill children
4
children comparison
4
comparison three
4
three dose
4
dose regimens
4
comment
1

Similar Publications

Rifaximin discontinuation during broad-spectrum antibiotic treatment in critically ill patients with hepatic encephalopathy.

World J Hepatol

November 2024

Department of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, Polo Pontino, Rome 00185, Italy.

Hepatic encephalopathy (HE) is one of the main complications of cirrhosis, characterized by a wide spectrum of neuropsychiatric alterations that lead to an increase in mortality, morbidity and recurrent hospitalizations. Due to the central role in HE pathogenesis of ammonia and other neurotoxins primarily produced by the gut microbiota, the main therapeutic approaches for the treatment of HE are based on the modulation of the gut microbiota. Rifaximin is a non-absorbable broad-spectrum antibiotic, that is effective against ammonia-producing gram-positive, gram-negative, and anaerobic species, approved for the treatment of HE in secondary prophylaxis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!